WNT3A and melanoma: To determine whether depletion of PKN1 can further activate β-catenin signaling elicited by WNT3A and BRAF inhibitor (BRAFi) in melanoma, we transfected A375 cells harboring BAR with siRNAs targeting PKN1 or control duplexes.